Advertisement

Related Videos

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Advertisement

Advertisement




Jan
27
Today In Oncology
Leader in Global Cancer Care, Paul E. Goss, MD, PhD, Dies at 70
New Report Shows Colorectal Cancer is Now Leading Cancer Death Among Those Under 50
Pembrolizumab Plus Lenvatinib in Recurrent Gynecologic Clear Cell Carcinoma
Cabozantinib and Temozolomide in Unresectable or Metastatic Leiomyosarcoma
Nutrition Muscle Loss Compromises Survival in Patients With Cervical Cancer Undergoing Chemoradiotherapy
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo